Pembrolizumab Boosts Survival Rates For Some Head, Neck Cancers - Kaiser Health News

Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.

Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup. ScienceDaily: Immunotherapy Drug Bolsters Head And Neck Cancer Tr… [+3647 chars]

full article...